Global Recombinant Coagulation Factor IX Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
LPI (LP Information)' newest research report, the “Recombinant Coagulation Factor IX Industry Forecast” looks at past sales and reviews total world Recombinant Coagulation Factor IX sales in 2022, providing a comprehensive analysis by region and market sector of projected Recombinant Coagulation Factor IX sales for 2023 through 2029. With Recombinant Coagulation Factor IX sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Recombinant Coagulation Factor IX industry.
This Insight Report provides a comprehensive analysis of the global Recombinant Coagulation Factor IX landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Recombinant Coagulation Factor IX portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Recombinant Coagulation Factor IX market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Recombinant Coagulation Factor IX and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Recombinant Coagulation Factor IX.
The global Recombinant Coagulation Factor IX market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Recombinant Coagulation Factor IX is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Recombinant Coagulation Factor IX is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Recombinant Coagulation Factor IX is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Recombinant Coagulation Factor IX players cover Pfizer, Rebinyn, CSL Behring, Takeda, Sanofi, Aptevo Bio Therapeutics and Thermo Fisher, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Recombinant Coagulation Factor IX market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Recombinant Coagulation Factor IX market?
What factors are driving Recombinant Coagulation Factor IX market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Recombinant Coagulation Factor IX market opportunities vary by end market size?
How does Recombinant Coagulation Factor IX break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
LPI (LP Information)' newest research report, the “Recombinant Coagulation Factor IX Industry Forecast” looks at past sales and reviews total world Recombinant Coagulation Factor IX sales in 2022, providing a comprehensive analysis by region and market sector of projected Recombinant Coagulation Factor IX sales for 2023 through 2029. With Recombinant Coagulation Factor IX sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Recombinant Coagulation Factor IX industry.
This Insight Report provides a comprehensive analysis of the global Recombinant Coagulation Factor IX landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Recombinant Coagulation Factor IX portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Recombinant Coagulation Factor IX market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Recombinant Coagulation Factor IX and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Recombinant Coagulation Factor IX.
The global Recombinant Coagulation Factor IX market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Recombinant Coagulation Factor IX is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Recombinant Coagulation Factor IX is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Recombinant Coagulation Factor IX is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Recombinant Coagulation Factor IX players cover Pfizer, Rebinyn, CSL Behring, Takeda, Sanofi, Aptevo Bio Therapeutics and Thermo Fisher, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Recombinant Coagulation Factor IX market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- 500 IU
- 1000 IU
- Other
- Adult
- Children
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Pfizer
- Rebinyn
- CSL Behring
- Takeda
- Sanofi
- Aptevo Bio Therapeutics
- Thermo Fisher
What is the 10-year outlook for the global Recombinant Coagulation Factor IX market?
What factors are driving Recombinant Coagulation Factor IX market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Recombinant Coagulation Factor IX market opportunities vary by end market size?
How does Recombinant Coagulation Factor IX break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Recombinant Coagulation Factor IX Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Recombinant Coagulation Factor IX by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Recombinant Coagulation Factor IX by Country/Region, 2018, 2022 & 2029
2.2 Recombinant Coagulation Factor IX Segment by Type
2.2.1 500 IU
2.2.2 1000 IU
2.2.3 Other
2.3 Recombinant Coagulation Factor IX Sales by Type
2.3.1 Global Recombinant Coagulation Factor IX Sales Market Share by Type (2018-2023)
2.3.2 Global Recombinant Coagulation Factor IX Revenue and Market Share by Type (2018-2023)
2.3.3 Global Recombinant Coagulation Factor IX Sale Price by Type (2018-2023)
2.4 Recombinant Coagulation Factor IX Segment by Application
2.4.1 Adult
2.4.2 Children
2.5 Recombinant Coagulation Factor IX Sales by Application
2.5.1 Global Recombinant Coagulation Factor IX Sale Market Share by Application (2018-2023)
2.5.2 Global Recombinant Coagulation Factor IX Revenue and Market Share by Application (2018-2023)
2.5.3 Global Recombinant Coagulation Factor IX Sale Price by Application (2018-2023)
3 GLOBAL RECOMBINANT COAGULATION FACTOR IX BY COMPANY
3.1 Global Recombinant Coagulation Factor IX Breakdown Data by Company
3.1.1 Global Recombinant Coagulation Factor IX Annual Sales by Company (2018-2023)
3.1.2 Global Recombinant Coagulation Factor IX Sales Market Share by Company (2018-2023)
3.2 Global Recombinant Coagulation Factor IX Annual Revenue by Company (2018-2023)
3.2.1 Global Recombinant Coagulation Factor IX Revenue by Company (2018-2023)
3.2.2 Global Recombinant Coagulation Factor IX Revenue Market Share by Company (2018-2023)
3.3 Global Recombinant Coagulation Factor IX Sale Price by Company
3.4 Key Manufacturers Recombinant Coagulation Factor IX Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Recombinant Coagulation Factor IX Product Location Distribution
3.4.2 Players Recombinant Coagulation Factor IX Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR RECOMBINANT COAGULATION FACTOR IX BY GEOGRAPHIC REGION
4.1 World Historic Recombinant Coagulation Factor IX Market Size by Geographic Region (2018-2023)
4.1.1 Global Recombinant Coagulation Factor IX Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Recombinant Coagulation Factor IX Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Recombinant Coagulation Factor IX Market Size by Country/Region (2018-2023)
4.2.1 Global Recombinant Coagulation Factor IX Annual Sales by Country/Region (2018-2023)
4.2.2 Global Recombinant Coagulation Factor IX Annual Revenue by Country/Region (2018-2023)
4.3 Americas Recombinant Coagulation Factor IX Sales Growth
4.4 APAC Recombinant Coagulation Factor IX Sales Growth
4.5 Europe Recombinant Coagulation Factor IX Sales Growth
4.6 Middle East & Africa Recombinant Coagulation Factor IX Sales Growth
5 AMERICAS
5.1 Americas Recombinant Coagulation Factor IX Sales by Country
5.1.1 Americas Recombinant Coagulation Factor IX Sales by Country (2018-2023)
5.1.2 Americas Recombinant Coagulation Factor IX Revenue by Country (2018-2023)
5.2 Americas Recombinant Coagulation Factor IX Sales by Type
5.3 Americas Recombinant Coagulation Factor IX Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Recombinant Coagulation Factor IX Sales by Region
6.1.1 APAC Recombinant Coagulation Factor IX Sales by Region (2018-2023)
6.1.2 APAC Recombinant Coagulation Factor IX Revenue by Region (2018-2023)
6.2 APAC Recombinant Coagulation Factor IX Sales by Type
6.3 APAC Recombinant Coagulation Factor IX Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Recombinant Coagulation Factor IX by Country
7.1.1 Europe Recombinant Coagulation Factor IX Sales by Country (2018-2023)
7.1.2 Europe Recombinant Coagulation Factor IX Revenue by Country (2018-2023)
7.2 Europe Recombinant Coagulation Factor IX Sales by Type
7.3 Europe Recombinant Coagulation Factor IX Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Recombinant Coagulation Factor IX by Country
8.1.1 Middle East & Africa Recombinant Coagulation Factor IX Sales by Country (2018-2023)
8.1.2 Middle East & Africa Recombinant Coagulation Factor IX Revenue by Country (2018-2023)
8.2 Middle East & Africa Recombinant Coagulation Factor IX Sales by Type
8.3 Middle East & Africa Recombinant Coagulation Factor IX Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Recombinant Coagulation Factor IX
10.3 Manufacturing Process Analysis of Recombinant Coagulation Factor IX
10.4 Industry Chain Structure of Recombinant Coagulation Factor IX
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Recombinant Coagulation Factor IX Distributors
11.3 Recombinant Coagulation Factor IX Customer
12 WORLD FORECAST REVIEW FOR RECOMBINANT COAGULATION FACTOR IX BY GEOGRAPHIC REGION
12.1 Global Recombinant Coagulation Factor IX Market Size Forecast by Region
12.1.1 Global Recombinant Coagulation Factor IX Forecast by Region (2024-2029)
12.1.2 Global Recombinant Coagulation Factor IX Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Recombinant Coagulation Factor IX Forecast by Type
12.7 Global Recombinant Coagulation Factor IX Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer Recombinant Coagulation Factor IX Product Portfolios and Specifications
13.1.3 Pfizer Recombinant Coagulation Factor IX Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 Rebinyn
13.2.1 Rebinyn Company Information
13.2.2 Rebinyn Recombinant Coagulation Factor IX Product Portfolios and Specifications
13.2.3 Rebinyn Recombinant Coagulation Factor IX Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Rebinyn Main Business Overview
13.2.5 Rebinyn Latest Developments
13.3 CSL Behring
13.3.1 CSL Behring Company Information
13.3.2 CSL Behring Recombinant Coagulation Factor IX Product Portfolios and Specifications
13.3.3 CSL Behring Recombinant Coagulation Factor IX Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 CSL Behring Main Business Overview
13.3.5 CSL Behring Latest Developments
13.4 Takeda
13.4.1 Takeda Company Information
13.4.2 Takeda Recombinant Coagulation Factor IX Product Portfolios and Specifications
13.4.3 Takeda Recombinant Coagulation Factor IX Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Takeda Main Business Overview
13.4.5 Takeda Latest Developments
13.5 Sanofi
13.5.1 Sanofi Company Information
13.5.2 Sanofi Recombinant Coagulation Factor IX Product Portfolios and Specifications
13.5.3 Sanofi Recombinant Coagulation Factor IX Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Sanofi Main Business Overview
13.5.5 Sanofi Latest Developments
13.6 Aptevo Bio Therapeutics
13.6.1 Aptevo Bio Therapeutics Company Information
13.6.2 Aptevo Bio Therapeutics Recombinant Coagulation Factor IX Product Portfolios and Specifications
13.6.3 Aptevo Bio Therapeutics Recombinant Coagulation Factor IX Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Aptevo Bio Therapeutics Main Business Overview
13.6.5 Aptevo Bio Therapeutics Latest Developments
13.7 Thermo Fisher
13.7.1 Thermo Fisher Company Information
13.7.2 Thermo Fisher Recombinant Coagulation Factor IX Product Portfolios and Specifications
13.7.3 Thermo Fisher Recombinant Coagulation Factor IX Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Thermo Fisher Main Business Overview
13.7.5 Thermo Fisher Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Recombinant Coagulation Factor IX Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Recombinant Coagulation Factor IX by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Recombinant Coagulation Factor IX by Country/Region, 2018, 2022 & 2029
2.2 Recombinant Coagulation Factor IX Segment by Type
2.2.1 500 IU
2.2.2 1000 IU
2.2.3 Other
2.3 Recombinant Coagulation Factor IX Sales by Type
2.3.1 Global Recombinant Coagulation Factor IX Sales Market Share by Type (2018-2023)
2.3.2 Global Recombinant Coagulation Factor IX Revenue and Market Share by Type (2018-2023)
2.3.3 Global Recombinant Coagulation Factor IX Sale Price by Type (2018-2023)
2.4 Recombinant Coagulation Factor IX Segment by Application
2.4.1 Adult
2.4.2 Children
2.5 Recombinant Coagulation Factor IX Sales by Application
2.5.1 Global Recombinant Coagulation Factor IX Sale Market Share by Application (2018-2023)
2.5.2 Global Recombinant Coagulation Factor IX Revenue and Market Share by Application (2018-2023)
2.5.3 Global Recombinant Coagulation Factor IX Sale Price by Application (2018-2023)
3 GLOBAL RECOMBINANT COAGULATION FACTOR IX BY COMPANY
3.1 Global Recombinant Coagulation Factor IX Breakdown Data by Company
3.1.1 Global Recombinant Coagulation Factor IX Annual Sales by Company (2018-2023)
3.1.2 Global Recombinant Coagulation Factor IX Sales Market Share by Company (2018-2023)
3.2 Global Recombinant Coagulation Factor IX Annual Revenue by Company (2018-2023)
3.2.1 Global Recombinant Coagulation Factor IX Revenue by Company (2018-2023)
3.2.2 Global Recombinant Coagulation Factor IX Revenue Market Share by Company (2018-2023)
3.3 Global Recombinant Coagulation Factor IX Sale Price by Company
3.4 Key Manufacturers Recombinant Coagulation Factor IX Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Recombinant Coagulation Factor IX Product Location Distribution
3.4.2 Players Recombinant Coagulation Factor IX Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR RECOMBINANT COAGULATION FACTOR IX BY GEOGRAPHIC REGION
4.1 World Historic Recombinant Coagulation Factor IX Market Size by Geographic Region (2018-2023)
4.1.1 Global Recombinant Coagulation Factor IX Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Recombinant Coagulation Factor IX Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Recombinant Coagulation Factor IX Market Size by Country/Region (2018-2023)
4.2.1 Global Recombinant Coagulation Factor IX Annual Sales by Country/Region (2018-2023)
4.2.2 Global Recombinant Coagulation Factor IX Annual Revenue by Country/Region (2018-2023)
4.3 Americas Recombinant Coagulation Factor IX Sales Growth
4.4 APAC Recombinant Coagulation Factor IX Sales Growth
4.5 Europe Recombinant Coagulation Factor IX Sales Growth
4.6 Middle East & Africa Recombinant Coagulation Factor IX Sales Growth
5 AMERICAS
5.1 Americas Recombinant Coagulation Factor IX Sales by Country
5.1.1 Americas Recombinant Coagulation Factor IX Sales by Country (2018-2023)
5.1.2 Americas Recombinant Coagulation Factor IX Revenue by Country (2018-2023)
5.2 Americas Recombinant Coagulation Factor IX Sales by Type
5.3 Americas Recombinant Coagulation Factor IX Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Recombinant Coagulation Factor IX Sales by Region
6.1.1 APAC Recombinant Coagulation Factor IX Sales by Region (2018-2023)
6.1.2 APAC Recombinant Coagulation Factor IX Revenue by Region (2018-2023)
6.2 APAC Recombinant Coagulation Factor IX Sales by Type
6.3 APAC Recombinant Coagulation Factor IX Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Recombinant Coagulation Factor IX by Country
7.1.1 Europe Recombinant Coagulation Factor IX Sales by Country (2018-2023)
7.1.2 Europe Recombinant Coagulation Factor IX Revenue by Country (2018-2023)
7.2 Europe Recombinant Coagulation Factor IX Sales by Type
7.3 Europe Recombinant Coagulation Factor IX Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Recombinant Coagulation Factor IX by Country
8.1.1 Middle East & Africa Recombinant Coagulation Factor IX Sales by Country (2018-2023)
8.1.2 Middle East & Africa Recombinant Coagulation Factor IX Revenue by Country (2018-2023)
8.2 Middle East & Africa Recombinant Coagulation Factor IX Sales by Type
8.3 Middle East & Africa Recombinant Coagulation Factor IX Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Recombinant Coagulation Factor IX
10.3 Manufacturing Process Analysis of Recombinant Coagulation Factor IX
10.4 Industry Chain Structure of Recombinant Coagulation Factor IX
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Recombinant Coagulation Factor IX Distributors
11.3 Recombinant Coagulation Factor IX Customer
12 WORLD FORECAST REVIEW FOR RECOMBINANT COAGULATION FACTOR IX BY GEOGRAPHIC REGION
12.1 Global Recombinant Coagulation Factor IX Market Size Forecast by Region
12.1.1 Global Recombinant Coagulation Factor IX Forecast by Region (2024-2029)
12.1.2 Global Recombinant Coagulation Factor IX Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Recombinant Coagulation Factor IX Forecast by Type
12.7 Global Recombinant Coagulation Factor IX Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer Recombinant Coagulation Factor IX Product Portfolios and Specifications
13.1.3 Pfizer Recombinant Coagulation Factor IX Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 Rebinyn
13.2.1 Rebinyn Company Information
13.2.2 Rebinyn Recombinant Coagulation Factor IX Product Portfolios and Specifications
13.2.3 Rebinyn Recombinant Coagulation Factor IX Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Rebinyn Main Business Overview
13.2.5 Rebinyn Latest Developments
13.3 CSL Behring
13.3.1 CSL Behring Company Information
13.3.2 CSL Behring Recombinant Coagulation Factor IX Product Portfolios and Specifications
13.3.3 CSL Behring Recombinant Coagulation Factor IX Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 CSL Behring Main Business Overview
13.3.5 CSL Behring Latest Developments
13.4 Takeda
13.4.1 Takeda Company Information
13.4.2 Takeda Recombinant Coagulation Factor IX Product Portfolios and Specifications
13.4.3 Takeda Recombinant Coagulation Factor IX Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Takeda Main Business Overview
13.4.5 Takeda Latest Developments
13.5 Sanofi
13.5.1 Sanofi Company Information
13.5.2 Sanofi Recombinant Coagulation Factor IX Product Portfolios and Specifications
13.5.3 Sanofi Recombinant Coagulation Factor IX Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Sanofi Main Business Overview
13.5.5 Sanofi Latest Developments
13.6 Aptevo Bio Therapeutics
13.6.1 Aptevo Bio Therapeutics Company Information
13.6.2 Aptevo Bio Therapeutics Recombinant Coagulation Factor IX Product Portfolios and Specifications
13.6.3 Aptevo Bio Therapeutics Recombinant Coagulation Factor IX Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Aptevo Bio Therapeutics Main Business Overview
13.6.5 Aptevo Bio Therapeutics Latest Developments
13.7 Thermo Fisher
13.7.1 Thermo Fisher Company Information
13.7.2 Thermo Fisher Recombinant Coagulation Factor IX Product Portfolios and Specifications
13.7.3 Thermo Fisher Recombinant Coagulation Factor IX Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Thermo Fisher Main Business Overview
13.7.5 Thermo Fisher Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Recombinant Coagulation Factor IX Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Recombinant Coagulation Factor IX Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of 500 IU
Table 4. Major Players of 1000 IU
Table 5. Major Players of Other
Table 6. Global Recombinant Coagulation Factor IX Sales by Type (2018-2023) & (K Units)
Table 7. Global Recombinant Coagulation Factor IX Sales Market Share by Type (2018-2023)
Table 8. Global Recombinant Coagulation Factor IX Revenue by Type (2018-2023) & ($ million)
Table 9. Global Recombinant Coagulation Factor IX Revenue Market Share by Type (2018-2023)
Table 10. Global Recombinant Coagulation Factor IX Sale Price by Type (2018-2023) & (US$/Unit)
Table 11. Global Recombinant Coagulation Factor IX Sales by Application (2018-2023) & (K Units)
Table 12. Global Recombinant Coagulation Factor IX Sales Market Share by Application (2018-2023)
Table 13. Global Recombinant Coagulation Factor IX Revenue by Application (2018-2023)
Table 14. Global Recombinant Coagulation Factor IX Revenue Market Share by Application (2018-2023)
Table 15. Global Recombinant Coagulation Factor IX Sale Price by Application (2018-2023) & (US$/Unit)
Table 16. Global Recombinant Coagulation Factor IX Sales by Company (2018-2023) & (K Units)
Table 17. Global Recombinant Coagulation Factor IX Sales Market Share by Company (2018-2023)
Table 18. Global Recombinant Coagulation Factor IX Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Recombinant Coagulation Factor IX Revenue Market Share by Company (2018-2023)
Table 20. Global Recombinant Coagulation Factor IX Sale Price by Company (2018-2023) & (US$/Unit)
Table 21. Key Manufacturers Recombinant Coagulation Factor IX Producing Area Distribution and Sales Area
Table 22. Players Recombinant Coagulation Factor IX Products Offered
Table 23. Recombinant Coagulation Factor IX Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Recombinant Coagulation Factor IX Sales by Geographic Region (2018-2023) & (K Units)
Table 27. Global Recombinant Coagulation Factor IX Sales Market Share Geographic Region (2018-2023)
Table 28. Global Recombinant Coagulation Factor IX Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Recombinant Coagulation Factor IX Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Recombinant Coagulation Factor IX Sales by Country/Region (2018-2023) & (K Units)
Table 31. Global Recombinant Coagulation Factor IX Sales Market Share by Country/Region (2018-2023)
Table 32. Global Recombinant Coagulation Factor IX Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Recombinant Coagulation Factor IX Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Recombinant Coagulation Factor IX Sales by Country (2018-2023) & (K Units)
Table 35. Americas Recombinant Coagulation Factor IX Sales Market Share by Country (2018-2023)
Table 36. Americas Recombinant Coagulation Factor IX Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Recombinant Coagulation Factor IX Revenue Market Share by Country (2018-2023)
Table 38. Americas Recombinant Coagulation Factor IX Sales by Type (2018-2023) & (K Units)
Table 39. Americas Recombinant Coagulation Factor IX Sales by Application (2018-2023) & (K Units)
Table 40. APAC Recombinant Coagulation Factor IX Sales by Region (2018-2023) & (K Units)
Table 41. APAC Recombinant Coagulation Factor IX Sales Market Share by Region (2018-2023)
Table 42. APAC Recombinant Coagulation Factor IX Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Recombinant Coagulation Factor IX Revenue Market Share by Region (2018-2023)
Table 44. APAC Recombinant Coagulation Factor IX Sales by Type (2018-2023) & (K Units)
Table 45. APAC Recombinant Coagulation Factor IX Sales by Application (2018-2023) & (K Units)
Table 46. Europe Recombinant Coagulation Factor IX Sales by Country (2018-2023) & (K Units)
Table 47. Europe Recombinant Coagulation Factor IX Sales Market Share by Country (2018-2023)
Table 48. Europe Recombinant Coagulation Factor IX Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Recombinant Coagulation Factor IX Revenue Market Share by Country (2018-2023)
Table 50. Europe Recombinant Coagulation Factor IX Sales by Type (2018-2023) & (K Units)
Table 51. Europe Recombinant Coagulation Factor IX Sales by Application (2018-2023) & (K Units)
Table 52. Middle East & Africa Recombinant Coagulation Factor IX Sales by Country (2018-2023) & (K Units)
Table 53. Middle East & Africa Recombinant Coagulation Factor IX Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Recombinant Coagulation Factor IX Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Recombinant Coagulation Factor IX Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Recombinant Coagulation Factor IX Sales by Type (2018-2023) & (K Units)
Table 57. Middle East & Africa Recombinant Coagulation Factor IX Sales by Application (2018-2023) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Recombinant Coagulation Factor IX
Table 59. Key Market Challenges & Risks of Recombinant Coagulation Factor IX
Table 60. Key Industry Trends of Recombinant Coagulation Factor IX
Table 61. Recombinant Coagulation Factor IX Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Recombinant Coagulation Factor IX Distributors List
Table 64. Recombinant Coagulation Factor IX Customer List
Table 65. Global Recombinant Coagulation Factor IX Sales Forecast by Region (2024-2029) & (K Units)
Table 66. Global Recombinant Coagulation Factor IX Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Recombinant Coagulation Factor IX Sales Forecast by Country (2024-2029) & (K Units)
Table 68. Americas Recombinant Coagulation Factor IX Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Recombinant Coagulation Factor IX Sales Forecast by Region (2024-2029) & (K Units)
Table 70. APAC Recombinant Coagulation Factor IX Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Recombinant Coagulation Factor IX Sales Forecast by Country (2024-2029) & (K Units)
Table 72. Europe Recombinant Coagulation Factor IX Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Recombinant Coagulation Factor IX Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Middle East & Africa Recombinant Coagulation Factor IX Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Recombinant Coagulation Factor IX Sales Forecast by Type (2024-2029) & (K Units)
Table 76. Global Recombinant Coagulation Factor IX Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Recombinant Coagulation Factor IX Sales Forecast by Application (2024-2029) & (K Units)
Table 78. Global Recombinant Coagulation Factor IX Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. Pfizer Basic Information, Recombinant Coagulation Factor IX Manufacturing Base, Sales Area and Its Competitors
Table 80. Pfizer Recombinant Coagulation Factor IX Product Portfolios and Specifications
Table 81. Pfizer Recombinant Coagulation Factor IX Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 82. Pfizer Main Business
Table 83. Pfizer Latest Developments
Table 84. Rebinyn Basic Information, Recombinant Coagulation Factor IX Manufacturing Base, Sales Area and Its Competitors
Table 85. Rebinyn Recombinant Coagulation Factor IX Product Portfolios and Specifications
Table 86. Rebinyn Recombinant Coagulation Factor IX Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 87. Rebinyn Main Business
Table 88. Rebinyn Latest Developments
Table 89. CSL Behring Basic Information, Recombinant Coagulation Factor IX Manufacturing Base, Sales Area and Its Competitors
Table 90. CSL Behring Recombinant Coagulation Factor IX Product Portfolios and Specifications
Table 91. CSL Behring Recombinant Coagulation Factor IX Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 92. CSL Behring Main Business
Table 93. CSL Behring Latest Developments
Table 94. Takeda Basic Information, Recombinant Coagulation Factor IX Manufacturing Base, Sales Area and Its Competitors
Table 95. Takeda Recombinant Coagulation Factor IX Product Portfolios and Specifications
Table 96. Takeda Recombinant Coagulation Factor IX Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 97. Takeda Main Business
Table 98. Takeda Latest Developments
Table 99. Sanofi Basic Information, Recombinant Coagulation Factor IX Manufacturing Base, Sales Area and Its Competitors
Table 100. Sanofi Recombinant Coagulation Factor IX Product Portfolios and Specifications
Table 101. Sanofi Recombinant Coagulation Factor IX Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 102. Sanofi Main Business
Table 103. Sanofi Latest Developments
Table 104. Aptevo Bio Therapeutics Basic Information, Recombinant Coagulation Factor IX Manufacturing Base, Sales Area and Its Competitors
Table 105. Aptevo Bio Therapeutics Recombinant Coagulation Factor IX Product Portfolios and Specifications
Table 106. Aptevo Bio Therapeutics Recombinant Coagulation Factor IX Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 107. Aptevo Bio Therapeutics Main Business
Table 108. Aptevo Bio Therapeutics Latest Developments
Table 109. Thermo Fisher Basic Information, Recombinant Coagulation Factor IX Manufacturing Base, Sales Area and Its Competitors
Table 110. Thermo Fisher Recombinant Coagulation Factor IX Product Portfolios and Specifications
Table 111. Thermo Fisher Recombinant Coagulation Factor IX Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 112. Thermo Fisher Main Business
Table 113. Thermo Fisher Latest Developments
Table 1. Recombinant Coagulation Factor IX Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Recombinant Coagulation Factor IX Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of 500 IU
Table 4. Major Players of 1000 IU
Table 5. Major Players of Other
Table 6. Global Recombinant Coagulation Factor IX Sales by Type (2018-2023) & (K Units)
Table 7. Global Recombinant Coagulation Factor IX Sales Market Share by Type (2018-2023)
Table 8. Global Recombinant Coagulation Factor IX Revenue by Type (2018-2023) & ($ million)
Table 9. Global Recombinant Coagulation Factor IX Revenue Market Share by Type (2018-2023)
Table 10. Global Recombinant Coagulation Factor IX Sale Price by Type (2018-2023) & (US$/Unit)
Table 11. Global Recombinant Coagulation Factor IX Sales by Application (2018-2023) & (K Units)
Table 12. Global Recombinant Coagulation Factor IX Sales Market Share by Application (2018-2023)
Table 13. Global Recombinant Coagulation Factor IX Revenue by Application (2018-2023)
Table 14. Global Recombinant Coagulation Factor IX Revenue Market Share by Application (2018-2023)
Table 15. Global Recombinant Coagulation Factor IX Sale Price by Application (2018-2023) & (US$/Unit)
Table 16. Global Recombinant Coagulation Factor IX Sales by Company (2018-2023) & (K Units)
Table 17. Global Recombinant Coagulation Factor IX Sales Market Share by Company (2018-2023)
Table 18. Global Recombinant Coagulation Factor IX Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Recombinant Coagulation Factor IX Revenue Market Share by Company (2018-2023)
Table 20. Global Recombinant Coagulation Factor IX Sale Price by Company (2018-2023) & (US$/Unit)
Table 21. Key Manufacturers Recombinant Coagulation Factor IX Producing Area Distribution and Sales Area
Table 22. Players Recombinant Coagulation Factor IX Products Offered
Table 23. Recombinant Coagulation Factor IX Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Recombinant Coagulation Factor IX Sales by Geographic Region (2018-2023) & (K Units)
Table 27. Global Recombinant Coagulation Factor IX Sales Market Share Geographic Region (2018-2023)
Table 28. Global Recombinant Coagulation Factor IX Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Recombinant Coagulation Factor IX Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Recombinant Coagulation Factor IX Sales by Country/Region (2018-2023) & (K Units)
Table 31. Global Recombinant Coagulation Factor IX Sales Market Share by Country/Region (2018-2023)
Table 32. Global Recombinant Coagulation Factor IX Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Recombinant Coagulation Factor IX Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Recombinant Coagulation Factor IX Sales by Country (2018-2023) & (K Units)
Table 35. Americas Recombinant Coagulation Factor IX Sales Market Share by Country (2018-2023)
Table 36. Americas Recombinant Coagulation Factor IX Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Recombinant Coagulation Factor IX Revenue Market Share by Country (2018-2023)
Table 38. Americas Recombinant Coagulation Factor IX Sales by Type (2018-2023) & (K Units)
Table 39. Americas Recombinant Coagulation Factor IX Sales by Application (2018-2023) & (K Units)
Table 40. APAC Recombinant Coagulation Factor IX Sales by Region (2018-2023) & (K Units)
Table 41. APAC Recombinant Coagulation Factor IX Sales Market Share by Region (2018-2023)
Table 42. APAC Recombinant Coagulation Factor IX Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Recombinant Coagulation Factor IX Revenue Market Share by Region (2018-2023)
Table 44. APAC Recombinant Coagulation Factor IX Sales by Type (2018-2023) & (K Units)
Table 45. APAC Recombinant Coagulation Factor IX Sales by Application (2018-2023) & (K Units)
Table 46. Europe Recombinant Coagulation Factor IX Sales by Country (2018-2023) & (K Units)
Table 47. Europe Recombinant Coagulation Factor IX Sales Market Share by Country (2018-2023)
Table 48. Europe Recombinant Coagulation Factor IX Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Recombinant Coagulation Factor IX Revenue Market Share by Country (2018-2023)
Table 50. Europe Recombinant Coagulation Factor IX Sales by Type (2018-2023) & (K Units)
Table 51. Europe Recombinant Coagulation Factor IX Sales by Application (2018-2023) & (K Units)
Table 52. Middle East & Africa Recombinant Coagulation Factor IX Sales by Country (2018-2023) & (K Units)
Table 53. Middle East & Africa Recombinant Coagulation Factor IX Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Recombinant Coagulation Factor IX Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Recombinant Coagulation Factor IX Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Recombinant Coagulation Factor IX Sales by Type (2018-2023) & (K Units)
Table 57. Middle East & Africa Recombinant Coagulation Factor IX Sales by Application (2018-2023) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Recombinant Coagulation Factor IX
Table 59. Key Market Challenges & Risks of Recombinant Coagulation Factor IX
Table 60. Key Industry Trends of Recombinant Coagulation Factor IX
Table 61. Recombinant Coagulation Factor IX Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Recombinant Coagulation Factor IX Distributors List
Table 64. Recombinant Coagulation Factor IX Customer List
Table 65. Global Recombinant Coagulation Factor IX Sales Forecast by Region (2024-2029) & (K Units)
Table 66. Global Recombinant Coagulation Factor IX Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Recombinant Coagulation Factor IX Sales Forecast by Country (2024-2029) & (K Units)
Table 68. Americas Recombinant Coagulation Factor IX Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Recombinant Coagulation Factor IX Sales Forecast by Region (2024-2029) & (K Units)
Table 70. APAC Recombinant Coagulation Factor IX Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Recombinant Coagulation Factor IX Sales Forecast by Country (2024-2029) & (K Units)
Table 72. Europe Recombinant Coagulation Factor IX Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Recombinant Coagulation Factor IX Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Middle East & Africa Recombinant Coagulation Factor IX Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Recombinant Coagulation Factor IX Sales Forecast by Type (2024-2029) & (K Units)
Table 76. Global Recombinant Coagulation Factor IX Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Recombinant Coagulation Factor IX Sales Forecast by Application (2024-2029) & (K Units)
Table 78. Global Recombinant Coagulation Factor IX Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. Pfizer Basic Information, Recombinant Coagulation Factor IX Manufacturing Base, Sales Area and Its Competitors
Table 80. Pfizer Recombinant Coagulation Factor IX Product Portfolios and Specifications
Table 81. Pfizer Recombinant Coagulation Factor IX Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 82. Pfizer Main Business
Table 83. Pfizer Latest Developments
Table 84. Rebinyn Basic Information, Recombinant Coagulation Factor IX Manufacturing Base, Sales Area and Its Competitors
Table 85. Rebinyn Recombinant Coagulation Factor IX Product Portfolios and Specifications
Table 86. Rebinyn Recombinant Coagulation Factor IX Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 87. Rebinyn Main Business
Table 88. Rebinyn Latest Developments
Table 89. CSL Behring Basic Information, Recombinant Coagulation Factor IX Manufacturing Base, Sales Area and Its Competitors
Table 90. CSL Behring Recombinant Coagulation Factor IX Product Portfolios and Specifications
Table 91. CSL Behring Recombinant Coagulation Factor IX Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 92. CSL Behring Main Business
Table 93. CSL Behring Latest Developments
Table 94. Takeda Basic Information, Recombinant Coagulation Factor IX Manufacturing Base, Sales Area and Its Competitors
Table 95. Takeda Recombinant Coagulation Factor IX Product Portfolios and Specifications
Table 96. Takeda Recombinant Coagulation Factor IX Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 97. Takeda Main Business
Table 98. Takeda Latest Developments
Table 99. Sanofi Basic Information, Recombinant Coagulation Factor IX Manufacturing Base, Sales Area and Its Competitors
Table 100. Sanofi Recombinant Coagulation Factor IX Product Portfolios and Specifications
Table 101. Sanofi Recombinant Coagulation Factor IX Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 102. Sanofi Main Business
Table 103. Sanofi Latest Developments
Table 104. Aptevo Bio Therapeutics Basic Information, Recombinant Coagulation Factor IX Manufacturing Base, Sales Area and Its Competitors
Table 105. Aptevo Bio Therapeutics Recombinant Coagulation Factor IX Product Portfolios and Specifications
Table 106. Aptevo Bio Therapeutics Recombinant Coagulation Factor IX Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 107. Aptevo Bio Therapeutics Main Business
Table 108. Aptevo Bio Therapeutics Latest Developments
Table 109. Thermo Fisher Basic Information, Recombinant Coagulation Factor IX Manufacturing Base, Sales Area and Its Competitors
Table 110. Thermo Fisher Recombinant Coagulation Factor IX Product Portfolios and Specifications
Table 111. Thermo Fisher Recombinant Coagulation Factor IX Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 112. Thermo Fisher Main Business
Table 113. Thermo Fisher Latest Developments
LIST OF FIGURES
Figure 1. Picture of Recombinant Coagulation Factor IX
Figure 2. Recombinant Coagulation Factor IX Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Recombinant Coagulation Factor IX Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Recombinant Coagulation Factor IX Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Recombinant Coagulation Factor IX Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of 500 IU
Figure 10. Product Picture of 1000 IU
Figure 11. Product Picture of Other
Figure 12. Global Recombinant Coagulation Factor IX Sales Market Share by Type in 2022
Figure 13. Global Recombinant Coagulation Factor IX Revenue Market Share by Type (2018-2023)
Figure 14. Recombinant Coagulation Factor IX Consumed in Adult
Figure 15. Global Recombinant Coagulation Factor IX Market: Adult (2018-2023) & (K Units)
Figure 16. Recombinant Coagulation Factor IX Consumed in Children
Figure 17. Global Recombinant Coagulation Factor IX Market: Children (2018-2023) & (K Units)
Figure 18. Global Recombinant Coagulation Factor IX Sales Market Share by Application (2022)
Figure 19. Global Recombinant Coagulation Factor IX Revenue Market Share by Application in 2022
Figure 20. Recombinant Coagulation Factor IX Sales Market by Company in 2022 (K Units)
Figure 21. Global Recombinant Coagulation Factor IX Sales Market Share by Company in 2022
Figure 22. Recombinant Coagulation Factor IX Revenue Market by Company in 2022 ($ Million)
Figure 23. Global Recombinant Coagulation Factor IX Revenue Market Share by Company in 2022
Figure 24. Global Recombinant Coagulation Factor IX Sales Market Share by Geographic Region (2018-2023)
Figure 25. Global Recombinant Coagulation Factor IX Revenue Market Share by Geographic Region in 2022
Figure 26. Americas Recombinant Coagulation Factor IX Sales 2018-2023 (K Units)
Figure 27. Americas Recombinant Coagulation Factor IX Revenue 2018-2023 ($ Millions)
Figure 28. APAC Recombinant Coagulation Factor IX Sales 2018-2023 (K Units)
Figure 29. APAC Recombinant Coagulation Factor IX Revenue 2018-2023 ($ Millions)
Figure 30. Europe Recombinant Coagulation Factor IX Sales 2018-2023 (K Units)
Figure 31. Europe Recombinant Coagulation Factor IX Revenue 2018-2023 ($ Millions)
Figure 32. Middle East & Africa Recombinant Coagulation Factor IX Sales 2018-2023 (K Units)
Figure 33. Middle East & Africa Recombinant Coagulation Factor IX Revenue 2018-2023 ($ Millions)
Figure 34. Americas Recombinant Coagulation Factor IX Sales Market Share by Country in 2022
Figure 35. Americas Recombinant Coagulation Factor IX Revenue Market Share by Country in 2022
Figure 36. Americas Recombinant Coagulation Factor IX Sales Market Share by Type (2018-2023)
Figure 37. Americas Recombinant Coagulation Factor IX Sales Market Share by Application (2018-2023)
Figure 38. United States Recombinant Coagulation Factor IX Revenue Growth 2018-2023 ($ Millions)
Figure 39. Canada Recombinant Coagulation Factor IX Revenue Growth 2018-2023 ($ Millions)
Figure 40. Mexico Recombinant Coagulation Factor IX Revenue Growth 2018-2023 ($ Millions)
Figure 41. Brazil Recombinant Coagulation Factor IX Revenue Growth 2018-2023 ($ Millions)
Figure 42. APAC Recombinant Coagulation Factor IX Sales Market Share by Region in 2022
Figure 43. APAC Recombinant Coagulation Factor IX Revenue Market Share by Regions in 2022
Figure 44. APAC Recombinant Coagulation Factor IX Sales Market Share by Type (2018-2023)
Figure 45. APAC Recombinant Coagulation Factor IX Sales Market Share by Application (2018-2023)
Figure 46. China Recombinant Coagulation Factor IX Revenue Growth 2018-2023 ($ Millions)
Figure 47. Japan Recombinant Coagulation Factor IX Revenue Growth 2018-2023 ($ Millions)
Figure 48. South Korea Recombinant Coagulation Factor IX Revenue Growth 2018-2023 ($ Millions)
Figure 49. Southeast Asia Recombinant Coagulation Factor IX Revenue Growth 2018-2023 ($ Millions)
Figure 50. India Recombinant Coagulation Factor IX Revenue Growth 2018-2023 ($ Millions)
Figure 51. Australia Recombinant Coagulation Factor IX Revenue Growth 2018-2023 ($ Millions)
Figure 52. China Taiwan Recombinant Coagulation Factor IX Revenue Growth 2018-2023 ($ Millions)
Figure 53. Europe Recombinant Coagulation Factor IX Sales Market Share by Country in 2022
Figure 54. Europe Recombinant Coagulation Factor IX Revenue Market Share by Country in 2022
Figure 55. Europe Recombinant Coagulation Factor IX Sales Market Share by Type (2018-2023)
Figure 56. Europe Recombinant Coagulation Factor IX Sales Market Share by Application (2018-2023)
Figure 57. Germany Recombinant Coagulation Factor IX Revenue Growth 2018-2023 ($ Millions)
Figure 58. France Recombinant Coagulation Factor IX Revenue Growth 2018-2023 ($ Millions)
Figure 59. UK Recombinant Coagulation Factor IX Revenue Growth 2018-2023 ($ Millions)
Figure 60. Italy Recombinant Coagulation Factor IX Revenue Growth 2018-2023 ($ Millions)
Figure 61. Russia Recombinant Coagulation Factor IX Revenue Growth 2018-2023 ($ Millions)
Figure 62. Middle East & Africa Recombinant Coagulation Factor IX Sales Market Share by Country in 2022
Figure 63. Middle East & Africa Recombinant Coagulation Factor IX Revenue Market Share by Country in 2022
Figure 64. Middle East & Africa Recombinant Coagulation Factor IX Sales Market Share by Type (2018-2023)
Figure 65. Middle East & Africa Recombinant Coagulation Factor IX Sales Market Share by Application (2018-2023)
Figure 66. Egypt Recombinant Coagulation Factor IX Revenue Growth 2018-2023 ($ Millions)
Figure 67. South Africa Recombinant Coagulation Factor IX Revenue Growth 2018-2023 ($ Millions)
Figure 68. Israel Recombinant Coagulation Factor IX Revenue Growth 2018-2023 ($ Millions)
Figure 69. Turkey Recombinant Coagulation Factor IX Revenue Growth 2018-2023 ($ Millions)
Figure 70. GCC Country Recombinant Coagulation Factor IX Revenue Growth 2018-2023 ($ Millions)
Figure 71. Manufacturing Cost Structure Analysis of Recombinant Coagulation Factor IX in 2022
Figure 72. Manufacturing Process Analysis of Recombinant Coagulation Factor IX
Figure 73. Industry Chain Structure of Recombinant Coagulation Factor IX
Figure 74. Channels of Distribution
Figure 75. Global Recombinant Coagulation Factor IX Sales Market Forecast by Region (2024-2029)
Figure 76. Global Recombinant Coagulation Factor IX Revenue Market Share Forecast by Region (2024-2029)
Figure 77. Global Recombinant Coagulation Factor IX Sales Market Share Forecast by Type (2024-2029)
Figure 78. Global Recombinant Coagulation Factor IX Revenue Market Share Forecast by Type (2024-2029)
Figure 79. Global Recombinant Coagulation Factor IX Sales Market Share Forecast by Application (2024-2029)
Figure 80. Global Recombinant Coagulation Factor IX Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Recombinant Coagulation Factor IX
Figure 2. Recombinant Coagulation Factor IX Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Recombinant Coagulation Factor IX Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Recombinant Coagulation Factor IX Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Recombinant Coagulation Factor IX Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of 500 IU
Figure 10. Product Picture of 1000 IU
Figure 11. Product Picture of Other
Figure 12. Global Recombinant Coagulation Factor IX Sales Market Share by Type in 2022
Figure 13. Global Recombinant Coagulation Factor IX Revenue Market Share by Type (2018-2023)
Figure 14. Recombinant Coagulation Factor IX Consumed in Adult
Figure 15. Global Recombinant Coagulation Factor IX Market: Adult (2018-2023) & (K Units)
Figure 16. Recombinant Coagulation Factor IX Consumed in Children
Figure 17. Global Recombinant Coagulation Factor IX Market: Children (2018-2023) & (K Units)
Figure 18. Global Recombinant Coagulation Factor IX Sales Market Share by Application (2022)
Figure 19. Global Recombinant Coagulation Factor IX Revenue Market Share by Application in 2022
Figure 20. Recombinant Coagulation Factor IX Sales Market by Company in 2022 (K Units)
Figure 21. Global Recombinant Coagulation Factor IX Sales Market Share by Company in 2022
Figure 22. Recombinant Coagulation Factor IX Revenue Market by Company in 2022 ($ Million)
Figure 23. Global Recombinant Coagulation Factor IX Revenue Market Share by Company in 2022
Figure 24. Global Recombinant Coagulation Factor IX Sales Market Share by Geographic Region (2018-2023)
Figure 25. Global Recombinant Coagulation Factor IX Revenue Market Share by Geographic Region in 2022
Figure 26. Americas Recombinant Coagulation Factor IX Sales 2018-2023 (K Units)
Figure 27. Americas Recombinant Coagulation Factor IX Revenue 2018-2023 ($ Millions)
Figure 28. APAC Recombinant Coagulation Factor IX Sales 2018-2023 (K Units)
Figure 29. APAC Recombinant Coagulation Factor IX Revenue 2018-2023 ($ Millions)
Figure 30. Europe Recombinant Coagulation Factor IX Sales 2018-2023 (K Units)
Figure 31. Europe Recombinant Coagulation Factor IX Revenue 2018-2023 ($ Millions)
Figure 32. Middle East & Africa Recombinant Coagulation Factor IX Sales 2018-2023 (K Units)
Figure 33. Middle East & Africa Recombinant Coagulation Factor IX Revenue 2018-2023 ($ Millions)
Figure 34. Americas Recombinant Coagulation Factor IX Sales Market Share by Country in 2022
Figure 35. Americas Recombinant Coagulation Factor IX Revenue Market Share by Country in 2022
Figure 36. Americas Recombinant Coagulation Factor IX Sales Market Share by Type (2018-2023)
Figure 37. Americas Recombinant Coagulation Factor IX Sales Market Share by Application (2018-2023)
Figure 38. United States Recombinant Coagulation Factor IX Revenue Growth 2018-2023 ($ Millions)
Figure 39. Canada Recombinant Coagulation Factor IX Revenue Growth 2018-2023 ($ Millions)
Figure 40. Mexico Recombinant Coagulation Factor IX Revenue Growth 2018-2023 ($ Millions)
Figure 41. Brazil Recombinant Coagulation Factor IX Revenue Growth 2018-2023 ($ Millions)
Figure 42. APAC Recombinant Coagulation Factor IX Sales Market Share by Region in 2022
Figure 43. APAC Recombinant Coagulation Factor IX Revenue Market Share by Regions in 2022
Figure 44. APAC Recombinant Coagulation Factor IX Sales Market Share by Type (2018-2023)
Figure 45. APAC Recombinant Coagulation Factor IX Sales Market Share by Application (2018-2023)
Figure 46. China Recombinant Coagulation Factor IX Revenue Growth 2018-2023 ($ Millions)
Figure 47. Japan Recombinant Coagulation Factor IX Revenue Growth 2018-2023 ($ Millions)
Figure 48. South Korea Recombinant Coagulation Factor IX Revenue Growth 2018-2023 ($ Millions)
Figure 49. Southeast Asia Recombinant Coagulation Factor IX Revenue Growth 2018-2023 ($ Millions)
Figure 50. India Recombinant Coagulation Factor IX Revenue Growth 2018-2023 ($ Millions)
Figure 51. Australia Recombinant Coagulation Factor IX Revenue Growth 2018-2023 ($ Millions)
Figure 52. China Taiwan Recombinant Coagulation Factor IX Revenue Growth 2018-2023 ($ Millions)
Figure 53. Europe Recombinant Coagulation Factor IX Sales Market Share by Country in 2022
Figure 54. Europe Recombinant Coagulation Factor IX Revenue Market Share by Country in 2022
Figure 55. Europe Recombinant Coagulation Factor IX Sales Market Share by Type (2018-2023)
Figure 56. Europe Recombinant Coagulation Factor IX Sales Market Share by Application (2018-2023)
Figure 57. Germany Recombinant Coagulation Factor IX Revenue Growth 2018-2023 ($ Millions)
Figure 58. France Recombinant Coagulation Factor IX Revenue Growth 2018-2023 ($ Millions)
Figure 59. UK Recombinant Coagulation Factor IX Revenue Growth 2018-2023 ($ Millions)
Figure 60. Italy Recombinant Coagulation Factor IX Revenue Growth 2018-2023 ($ Millions)
Figure 61. Russia Recombinant Coagulation Factor IX Revenue Growth 2018-2023 ($ Millions)
Figure 62. Middle East & Africa Recombinant Coagulation Factor IX Sales Market Share by Country in 2022
Figure 63. Middle East & Africa Recombinant Coagulation Factor IX Revenue Market Share by Country in 2022
Figure 64. Middle East & Africa Recombinant Coagulation Factor IX Sales Market Share by Type (2018-2023)
Figure 65. Middle East & Africa Recombinant Coagulation Factor IX Sales Market Share by Application (2018-2023)
Figure 66. Egypt Recombinant Coagulation Factor IX Revenue Growth 2018-2023 ($ Millions)
Figure 67. South Africa Recombinant Coagulation Factor IX Revenue Growth 2018-2023 ($ Millions)
Figure 68. Israel Recombinant Coagulation Factor IX Revenue Growth 2018-2023 ($ Millions)
Figure 69. Turkey Recombinant Coagulation Factor IX Revenue Growth 2018-2023 ($ Millions)
Figure 70. GCC Country Recombinant Coagulation Factor IX Revenue Growth 2018-2023 ($ Millions)
Figure 71. Manufacturing Cost Structure Analysis of Recombinant Coagulation Factor IX in 2022
Figure 72. Manufacturing Process Analysis of Recombinant Coagulation Factor IX
Figure 73. Industry Chain Structure of Recombinant Coagulation Factor IX
Figure 74. Channels of Distribution
Figure 75. Global Recombinant Coagulation Factor IX Sales Market Forecast by Region (2024-2029)
Figure 76. Global Recombinant Coagulation Factor IX Revenue Market Share Forecast by Region (2024-2029)
Figure 77. Global Recombinant Coagulation Factor IX Sales Market Share Forecast by Type (2024-2029)
Figure 78. Global Recombinant Coagulation Factor IX Revenue Market Share Forecast by Type (2024-2029)
Figure 79. Global Recombinant Coagulation Factor IX Sales Market Share Forecast by Application (2024-2029)
Figure 80. Global Recombinant Coagulation Factor IX Revenue Market Share Forecast by Application (2024-2029)
